FDA denies nasal spray alternative to EpiPen

ViewFederal regulators called for additional study of Neffy, a nasal spray that could provide an alternative to EpiPens for type 1 allergic reactions, surprising its maker ARS Pharmaceuticals on Wednesday. 

ARS said the Food and Drug Administration requested a "pharmacokinetic/pharmacodynamic study assessing repeat doses of...